Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (231-240 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Compounds as CDK2 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel TYK2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Pyrrolopyrazine Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic DermatitisRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Pyrrolidines as Main Protease Inhibitors for Treating Viral Infections, in Particular, Coronavirus InfectionsRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel 6-Substituted-3-Phenylisoindolin-1-ones as Cbl-B Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Triazine Derivatives as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS DisordersRam W Sabnis
Ecotoxicology and Environmental Safety|January 5, 2021
Perfluoroalkyl acids and their isomers, diabetes, anemia, and albuminuria: Variabilities with deteriorating kidney functionRam B Jain
Pageof 2,416

Showing results (231-240 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Compounds as CDK2 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel TYK2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Pyrrolopyrazine Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic DermatitisRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Pyrrolidines as Main Protease Inhibitors for Treating Viral Infections, in Particular, Coronavirus InfectionsRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel 6-Substituted-3-Phenylisoindolin-1-ones as Cbl-B Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Triazine Derivatives as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS DisordersRam W Sabnis
Ecotoxicology and Environmental Safety|January 5, 2021
Perfluoroalkyl acids and their isomers, diabetes, anemia, and albuminuria: Variabilities with deteriorating kidney functionRam B Jain
Pageof 2,416